IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX) have earned an average rating of “Moderate Buy” from the six ratings firms that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $53.3333.

Several equities research analysts recently commented on IPX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of IperionX in a report on Friday, July 17th. Roth Capital set a $53.00 target price on shares of IperionX in a research report on Wednesday. BTIG Research boosted their target price on shares of IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday, June 5th. Finally, Alliance Global Partners restated a “buy” rating on shares of IperionX in a research report on Tuesday, April 28th.

IperionX Price Performance

Shares of IPX stock opened at $23.77 on Thursday. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03. The stock has a 50 day simple moving average of $28.91 and a 200-day simple moving average of $35.21. IperionX has a 1-year low of $20.09 and a 1-year high of $61.45.

Insider Transactions at IperionX

In other IperionX news, CEO Anastasios Arima purchased 138,720 shares of the firm’s stock in a transaction dated Friday, July 10th. The shares were purchased at an average cost of $3.58 per share, with a total value of $496,617.60. Following the completion of the purchase, the chief executive officer owned 12,455,502 shares in the company, valued at approximately $44,590,697.16. This represents a 1.13% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Chairman Todd Hannigan purchased 300,000 shares of the stock in a transaction that occurred on Monday, July 13th. The shares were acquired at an average price of $3.59 per share, for a total transaction of $1,077,000.00. Following the completion of the transaction, the chairman directly owned 26,633,334 shares of the company’s stock, valued at $95,613,669.06. The trade was a 1.14% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought 663,720 shares of company stock valued at $2,379,118 over the last quarter.

Institutional Trading of IperionX

Several hedge funds have recently made changes to their positions in IPX. Private Advisor Group LLC grew its position in IperionX by 69.9% in the first quarter. Private Advisor Group LLC now owns 63,111 shares of the company’s stock worth $1,643,000 after acquiring an additional 25,964 shares during the period. JPMorgan Chase & Co. purchased a new stake in IperionX during the second quarter worth about $66,000. Corigliano Investment Advisers LLC acquired a new stake in IperionX during the 4th quarter worth approximately $362,000. XY Capital Ltd acquired a new stake in shares of IperionX in the fourth quarter valued at $290,000. Finally, XTX Topco Ltd acquired a new stake in IperionX in the 4th quarter valued at about $302,000. Hedge funds and other institutional investors own 2.76% of the company’s stock.

IperionX Company Profile

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.